PURE Bioscience (OTCMKTS:PURE – Get Free Report) shares passed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $0.06 and traded as high as $0.0749. PURE Bioscience shares last traded at $0.07, with a volume of 44,351 shares traded.
PURE Bioscience Price Performance
The firm has a market cap of $9.10 million, a PE ratio of -2.33 and a beta of 0.11. The company has a 50 day simple moving average of $0.08 and a 200-day simple moving average of $0.06.
PURE Bioscience (OTCMKTS:PURE – Get Free Report) last released its quarterly earnings data on Monday, March 16th. The company reported ($0.01) earnings per share for the quarter. The firm had revenue of $0.44 million during the quarter.
PURE Bioscience Company Profile
PURE Bioscience, Inc is a San Diego, California–based company that develops and markets patented antimicrobial solutions for diverse industries. At the core of its technology portfolio is Silver Dihydrogen Citrate (SDC), an EPA-registered broad-spectrum biocide designed to neutralize bacteria, viruses, and fungi on contact. The company targets applications in food processing, water treatment, personal care, and medical device sanitation.
PURE’s product suite includes concentrate formulations and ready-to-use solutions.
Recommended Stories
- Five stocks we like better than PURE Bioscience
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.
